| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 SMARCA5 SETX ERCC6 HSPA4L HSPH1 SMC4 SMC5 MYO5C BPTF SMC3 ATP6V1D SMARCA1 DDX60L HSPA5 DYNC1H1 | 1.73e-05 | 614 | 151 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | rRNA (cytosine-N4-)-methyltransferase activity | 5.68e-05 | 2 | 151 | 2 | GO:0071424 | |
| GeneOntologyMolecularFunction | DNA/DNA annealing activity | 6.69e-05 | 11 | 151 | 3 | GO:1990814 | |
| GeneOntologyMolecularFunction | annealing activity | 1.45e-04 | 14 | 151 | 3 | GO:0140666 | |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.70e-04 | 3 | 151 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 3.76e-04 | 19 | 151 | 3 | GO:1990825 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 4.40e-04 | 20 | 151 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 5.60e-04 | 5 | 151 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | rRNA (cytosine) methyltransferase activity | 8.35e-04 | 6 | 151 | 2 | GO:0016434 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 8.63e-04 | 25 | 151 | 3 | GO:0017056 | |
| GeneOntologyCellularComponent | ISWI-type complex | 2.61e-06 | 14 | 153 | 4 | GO:0031010 | |
| GeneOntologyCellularComponent | NURF complex | 1.32e-05 | 7 | 153 | 3 | GO:0016589 | |
| GeneOntologyCellularComponent | ATPase complex | 4.65e-05 | 129 | 153 | 7 | GO:1904949 | |
| GeneOntologyCellularComponent | ACF complex | 5.32e-05 | 2 | 153 | 2 | GO:0016590 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 7.51e-05 | 96 | 153 | 6 | GO:0070603 | |
| GeneOntologyCellularComponent | CHRAC | 3.16e-04 | 4 | 153 | 2 | GO:0008623 | |
| GeneOntologyCellularComponent | nuclear chromosome | 5.79e-04 | 254 | 153 | 8 | GO:0000228 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 7.38e-04 | 97 | 153 | 5 | GO:0071013 | |
| GeneOntologyCellularComponent | nucleoplasmic periphery of the nuclear pore complex | 7.83e-04 | 6 | 153 | 2 | GO:1990826 | |
| MousePheno | skeletal muscle hypoplasia | 2.24e-08 | 5 | 116 | 4 | MP:0009460 | |
| MousePheno | muscle hypoplasia | 5.73e-06 | 15 | 116 | 4 | MP:0000734 | |
| MousePheno | decreased pons size | 6.83e-05 | 2 | 116 | 2 | MP:0020533 | |
| MousePheno | tongue muscle hypoplasia | 6.83e-05 | 2 | 116 | 2 | MP:0030421 | |
| Domain | RecF/RecN/SMC_N | 2.76e-05 | 8 | 150 | 3 | IPR003395 | |
| Domain | SMC_N | 2.76e-05 | 8 | 150 | 3 | PF02463 | |
| Domain | SLIDE | 6.41e-05 | 2 | 150 | 2 | IPR015195 | |
| Domain | ISWI_HAND-dom | 6.41e-05 | 2 | 150 | 2 | IPR015194 | |
| Domain | SLIDE | 6.41e-05 | 2 | 150 | 2 | PF09111 | |
| Domain | HAND | 6.41e-05 | 2 | 150 | 2 | PF09110 | |
| Domain | ISWI | 6.41e-05 | 2 | 150 | 2 | IPR029915 | |
| Domain | - | 1.06e-04 | 12 | 150 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.06e-04 | 12 | 150 | 3 | IPR029047 | |
| Domain | - | 1.37e-04 | 13 | 150 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.37e-04 | 13 | 150 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.37e-04 | 13 | 150 | 3 | IPR029048 | |
| Domain | HnRNPA1 | 1.91e-04 | 3 | 150 | 2 | IPR021662 | |
| Domain | DBINO | 1.91e-04 | 3 | 150 | 2 | IPR020838 | |
| Domain | HnRNPA1 | 1.91e-04 | 3 | 150 | 2 | PF11627 | |
| Domain | DBINO | 1.91e-04 | 3 | 150 | 2 | PF13892 | |
| Domain | HSP70 | 2.63e-04 | 16 | 150 | 3 | PF00012 | |
| Domain | HSP70_2 | 3.18e-04 | 17 | 150 | 3 | PS00329 | |
| Domain | HSP70_1 | 3.18e-04 | 17 | 150 | 3 | PS00297 | |
| Domain | HSP70_3 | 3.18e-04 | 17 | 150 | 3 | PS01036 | |
| Domain | Hsp_70_fam | 3.79e-04 | 18 | 150 | 3 | IPR013126 | |
| Domain | TEX28/TMCC | 3.80e-04 | 4 | 150 | 2 | IPR019394 | |
| Domain | Tmemb_cc2 | 3.80e-04 | 4 | 150 | 2 | PF10267 | |
| Domain | DDT | 3.80e-04 | 4 | 150 | 2 | PF02791 | |
| Domain | Aldolase_II | 3.80e-04 | 4 | 150 | 2 | SM01007 | |
| Domain | Aldolase_II/adducin_N | 3.80e-04 | 4 | 150 | 2 | IPR001303 | |
| Domain | Aldolase_II | 3.80e-04 | 4 | 150 | 2 | PF00596 | |
| Domain | - | 3.80e-04 | 4 | 150 | 2 | 3.40.225.10 | |
| Domain | DCN-prot | 6.31e-04 | 5 | 150 | 2 | IPR014764 | |
| Domain | DDT | 6.31e-04 | 5 | 150 | 2 | SM00571 | |
| Domain | DOCK_N | 6.31e-04 | 5 | 150 | 2 | PF16172 | |
| Domain | DOCK_N | 6.31e-04 | 5 | 150 | 2 | IPR032376 | |
| Domain | SMC | 6.31e-04 | 5 | 150 | 2 | IPR024704 | |
| Domain | PONY_dom | 6.31e-04 | 5 | 150 | 2 | IPR005176 | |
| Domain | DCUN1 | 6.31e-04 | 5 | 150 | 2 | PS51229 | |
| Domain | DDT_dom | 6.31e-04 | 5 | 150 | 2 | IPR018501 | |
| Domain | WHIM1_dom | 6.31e-04 | 5 | 150 | 2 | IPR028942 | |
| Domain | WHIM2_dom | 6.31e-04 | 5 | 150 | 2 | IPR028941 | |
| Domain | WSD | 6.31e-04 | 5 | 150 | 2 | PF15613 | |
| Domain | WHIM1 | 6.31e-04 | 5 | 150 | 2 | PF15612 | |
| Domain | Cullin_binding | 6.31e-04 | 5 | 150 | 2 | PF03556 | |
| Domain | DDT | 9.41e-04 | 6 | 150 | 2 | PS50827 | |
| Domain | SMC_hinge | 9.41e-04 | 6 | 150 | 2 | SM00968 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 9.41e-04 | 6 | 150 | 2 | IPR016332 | |
| Domain | SMC_hinge | 9.41e-04 | 6 | 150 | 2 | PF06470 | |
| Domain | SMC_hinge | 9.41e-04 | 6 | 150 | 2 | IPR010935 | |
| Domain | TFR_dimer | 9.41e-04 | 6 | 150 | 2 | PF04253 | |
| Domain | - | 9.41e-04 | 6 | 150 | 2 | 1.20.930.40 | |
| Domain | - | DNAH3 DLG5 SMARCA5 SETX ERCC6 SMC4 ATL3 SMC5 NPHP3 SMC3 HNRNPUL2 SMARCA1 DDX60L DYNC1H1 CNP | 9.98e-04 | 746 | 150 | 15 | 3.40.50.300 |
| Domain | SANT_dom | 1.15e-03 | 26 | 150 | 3 | IPR017884 | |
| Domain | Bromodomain_CS | 1.15e-03 | 26 | 150 | 3 | IPR018359 | |
| Domain | TFR-like_dimer_dom | 1.31e-03 | 7 | 150 | 2 | IPR007365 | |
| Domain | P-loop_NTPase | DNAH3 DLG5 SMARCA5 SETX ERCC6 SMC4 ATL3 SMC5 MYO5C NPHP3 SMC3 HNRNPUL2 SMARCA1 DDX60L DYNC1H1 CNP | 1.32e-03 | 848 | 150 | 16 | IPR027417 |
| Domain | SANT | 1.44e-03 | 28 | 150 | 3 | PS51293 | |
| Domain | MHC_II_b_N | 1.74e-03 | 8 | 150 | 2 | PD000328 | |
| Domain | SH3 | 1.83e-03 | 216 | 150 | 7 | PS50002 | |
| Domain | SH3_domain | 2.03e-03 | 220 | 150 | 7 | IPR001452 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.12e-03 | 32 | 150 | 3 | PF00176 | |
| Domain | MHC_II_b_N | 2.22e-03 | 9 | 150 | 2 | IPR000353 | |
| Domain | MHC_II_beta | 2.22e-03 | 9 | 150 | 2 | SM00921 | |
| Domain | MHC_II_beta | 2.22e-03 | 9 | 150 | 2 | PF00969 | |
| Domain | BROMODOMAIN_1 | 3.23e-03 | 37 | 150 | 3 | PS00633 | |
| Domain | DHR-1_domain | 3.36e-03 | 11 | 150 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.36e-03 | 11 | 150 | 2 | PS51651 | |
| Domain | DHR_1 | 3.36e-03 | 11 | 150 | 2 | PS51650 | |
| Domain | DHR-2 | 3.36e-03 | 11 | 150 | 2 | PF06920 | |
| Domain | DOCK | 3.36e-03 | 11 | 150 | 2 | IPR026791 | |
| Domain | DOCK_C | 3.36e-03 | 11 | 150 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.36e-03 | 11 | 150 | 2 | PF14429 | |
| Domain | DHR-2 | 3.36e-03 | 11 | 150 | 2 | IPR027357 | |
| Domain | Bromodomain | 3.49e-03 | 38 | 150 | 3 | PF00439 | |
| Domain | MATH | 4.01e-03 | 12 | 150 | 2 | PS50144 | |
| Domain | Peptidase_M28 | 4.01e-03 | 12 | 150 | 2 | PF04389 | |
| Domain | Peptidase_M28 | 4.01e-03 | 12 | 150 | 2 | IPR007484 | |
| Domain | MATH/TRAF_dom | 4.01e-03 | 12 | 150 | 2 | IPR002083 | |
| Domain | MATH | 4.01e-03 | 12 | 150 | 2 | SM00061 | |
| Domain | MATH | 4.01e-03 | 12 | 150 | 2 | PF00917 | |
| Domain | BROMODOMAIN_2 | 4.33e-03 | 41 | 150 | 3 | PS50014 | |
| Domain | Bromodomain | 4.63e-03 | 42 | 150 | 3 | IPR001487 | |
| Domain | BROMO | 4.63e-03 | 42 | 150 | 3 | SM00297 | |
| Domain | - | 4.63e-03 | 42 | 150 | 3 | 1.20.920.10 | |
| Domain | MHC_II_a/b_N | 5.47e-03 | 14 | 150 | 2 | IPR014745 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.47e-03 | 14 | 150 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.47e-03 | 14 | 150 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.47e-03 | 14 | 150 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.47e-03 | 14 | 150 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.47e-03 | 14 | 150 | 2 | IPR011704 | |
| Domain | MT | 5.47e-03 | 14 | 150 | 2 | PF12777 | |
| Domain | AAA_8 | 5.47e-03 | 14 | 150 | 2 | PF12780 | |
| Domain | - | 5.47e-03 | 14 | 150 | 2 | 3.10.320.10 | |
| Domain | AAA_5 | 5.47e-03 | 14 | 150 | 2 | PF07728 | |
| Domain | DHC_fam | 6.28e-03 | 15 | 150 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.28e-03 | 15 | 150 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.28e-03 | 15 | 150 | 2 | IPR004273 | |
| Domain | ER_TARGET | 6.36e-03 | 47 | 150 | 3 | PS00014 | |
| Domain | - | 6.59e-03 | 207 | 150 | 6 | 1.25.40.10 | |
| Domain | P4Hc | 7.14e-03 | 16 | 150 | 2 | SM00702 | |
| Domain | Pro_4_hyd_alph | 7.14e-03 | 16 | 150 | 2 | IPR006620 | |
| Domain | TPR-contain_dom | 7.29e-03 | 150 | 150 | 5 | IPR013026 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 8.51e-06 | 39 | 102 | 5 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 9.67e-06 | 40 | 102 | 5 | M41816 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 1.24e-05 | 42 | 102 | 5 | M41828 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.39e-05 | 43 | 102 | 5 | M41827 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 1.39e-05 | 43 | 102 | 5 | MM15679 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.42e-05 | 73 | 102 | 6 | MM14948 | |
| Pathway | REACTOME_RND2_GTPASE_CYCLE | 1.56e-05 | 44 | 102 | 5 | MM15678 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.78e-05 | 82 | 102 | 6 | M27250 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.34e-05 | 92 | 102 | 6 | MM14951 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.00e-05 | 101 | 102 | 6 | M27253 | |
| Pathway | WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION | 1.26e-04 | 14 | 102 | 3 | M39772 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.42e-04 | 37 | 102 | 4 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 1.42e-04 | 37 | 102 | 4 | MM15610 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 2.34e-04 | 42 | 102 | 4 | M41826 | |
| Pathway | REACTOME_RND3_GTPASE_CYCLE | 2.34e-04 | 42 | 102 | 4 | MM15677 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.35e-04 | 77 | 102 | 5 | M27226 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 3.34e-04 | 46 | 102 | 4 | MM15949 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.53e-04 | 84 | 102 | 5 | MM14929 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.15e-04 | 87 | 102 | 5 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 4.38e-04 | 88 | 102 | 5 | M41810 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 4.61e-04 | 50 | 102 | 4 | M39822 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DLG5 SMARCA5 PLOD3 ERCC6 KRT18 HSPH1 SMC4 KRI1 SRP72 HNRNPA1 ERLIN1 ADD1 ADD3 NUP54 NCOA5 PPP1R10 CRNKL1 DST TCERG1 SMC3 HNRNPUL2 SMARCA1 USP7 RAI14 LTV1 EIF3A NUP93 LAS1L HSPA5 DYNC1H1 CNP SDHA | 1.02e-15 | 1257 | 155 | 32 | 36526897 |
| Pubmed | SMARCA5 NUP107 HSPA4L HSPH1 KRI1 SRP72 MYO5C NUP54 BPTF DST GSE1 ZFHX4 TCERG1 SMC3 HNRNPUL2 SUDS3 NFIC HGS NFRKB SMARCA1 USP7 KCTD15 RAI14 LTV1 EIF3A NUP93 HERC1 LAS1L TAF1L DYNC1H1 FILIP1L SORL1 | 3.52e-14 | 1429 | 155 | 32 | 35140242 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PHLDB3 SMARCA5 SETX ERCC6 NUP107 KRT18 HSPH1 SMC4 ATL3 HNRNPA1 ERLIN1 CRNKL1 POLR3B DST NF1 TCERG1 SMC3 HNRNPUL2 BAZ1A SMARCA1 USP7 RAI14 LTV1 EIF3A DDX60L NUP93 ALDH1B1 LAS1L HSPA5 DYNC1H1 CNP | 5.15e-14 | 1353 | 155 | 31 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SMARCA5 ERP44 NUP107 KRT18 SMC4 HNRNPA1 ERLIN1 MYO5C NUP54 NCOA5 BPTF PPP1R10 CRNKL1 DST NF1 SMC3 HNRNPUL2 BAZ1A ZC3H4 VANGL1 EIF3A NUP93 LAS1L HSPA5 DYNC1H1 CNP | 7.36e-13 | 1024 | 155 | 26 | 24711643 |
| Pubmed | DOCK1 DLG5 HSPA4L HSPH1 SMC4 SRP72 HNRNPA1 ERLIN1 ADD1 KIDINS220 DST TCERG1 SMC3 VANGL1 HGS BUB1B RAI14 LTV1 HSPA5 DYNC1H1 CNP SDHA | 1.02e-12 | 708 | 155 | 22 | 39231216 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SMARCA5 ERP44 NUP107 CACNA2D2 HSPA4L HSPH1 SMC4 KRI1 SRP72 GRM1 HNRNPA1 NCOA5 CRNKL1 KIDINS220 NF1 TCERG1 SMC3 HNRNPUL2 BAZ1A SMARCA1 USP7 LTV1 EIF3A NUP93 ALDH1B1 HNRNPLL HSPA5 DYNC1H1 SDHA | 6.87e-12 | 1425 | 155 | 29 | 30948266 |
| Pubmed | DLG5 SMARCA5 PLOD3 SRSF4 NUP107 KRT18 HSPA4L HSPH1 SMC4 SRP72 HNRNPA1 ERLIN1 ADD1 TGFB2 CRNKL1 SMC3 PIK3R1 HGS USP7 RAI14 LIMCH1 NUP93 ALDH1B1 HNRNPLL HSPA5 DYNC1H1 SDHA | 9.99e-12 | 1247 | 155 | 27 | 27684187 | |
| Pubmed | DLG5 SETX PLOD3 ERCC6 CWC27 HSPH1 SMC4 SRP72 ERLIN1 PPP1R10 CRNKL1 KIDINS220 DST TCERG1 BAZ1A VANGL1 MTFR1 NFRKB USP7 RAI14 EIF3A LIMCH1 DNAJC1 LAS1L TAF1L HNRNPLL CNP SDHA | 1.17e-10 | 1497 | 155 | 28 | 31527615 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | SMARCA5 NUP107 HSPA4L HSPH1 ADD1 ZFHX4 ZBED4 TCERG1 SMC3 BAZ1A SUDS3 NFIC HGS USP7 EIF3A HSPA5 CNP SDHA | 1.50e-10 | 583 | 155 | 18 | 29844126 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DLG5 SMARCA5 KRT18 HSPH1 SMC4 SRP72 HNRNPA1L2 HNRNPA1 MYO5C CRNKL1 DST TCERG1 SMC3 HNRNPUL2 USP7 RAI14 EIF3A LIMCH1 NUP93 LAS1L HSPA5 DYNC1H1 | 2.85e-10 | 949 | 155 | 22 | 36574265 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PLOD3 SRSF4 ERP44 HSPA4L PPP2R3B SMC4 ATL3 KRI1 HNRNPA1L2 ERLIN1 KIDINS220 SMC3 HNRNPUL2 VANGL1 EIF3A NUP93 ESPL1 HNRNPLL HSPA5 CNP SDHA SORL1 | 4.62e-10 | 974 | 155 | 22 | 28675297 |
| Pubmed | SMARCA5 NUP107 CWC27 HSPH1 SMC4 ADD1 NUP54 PPP1R10 POLR3B TCERG1 SMC3 BAZ1A NUP93 LAS1L HSPA5 DYNC1H1 SDHA | 6.48e-10 | 560 | 155 | 17 | 35241646 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SMARCA5 PLOD3 ERCC6 HSPA4L HSPH1 SMC4 SMC5 PPP1R10 CRNKL1 VPS13D SMC3 ZC3H4 USP7 RAI14 LIMCH1 HERC1 | 9.18e-10 | 497 | 155 | 16 | 36774506 |
| Pubmed | SMARCA5 PLOD3 SRSF4 NUP107 KRT18 CWC27 HNRNPA1 NUP54 DST TCERG1 SMC3 HNRNPUL2 BAZ1A SMARCA1 USP7 EIF3A NUP93 CNP | 1.08e-09 | 660 | 155 | 18 | 32780723 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK1 DOCK2 SMARCA5 SETX SRSF4 NUP107 SMC4 SRP72 HNRNPA1 NF1 SMC3 BUB1B NUP93 LAS1L HNRNPLL HSPA5 DYNC1H1 | 1.16e-09 | 582 | 155 | 17 | 20467437 |
| Pubmed | PLOD3 KRT18 HSPA4L HLA-DPB1 HSPH1 NCF1 SMC4 KRI1 SRP72 ERLIN1 POLR3B DST HNRNPUL2 BUB1B USP7 PCMTD2 EIF3A LIMCH1 DDX60L DNAJC1 NUP93 ALDH1B1 LAS1L DYNC1H1 CNP SDHA | 1.24e-09 | 1440 | 155 | 26 | 30833792 | |
| Pubmed | SETX PLOD3 ERP44 DCUN1D5 KRT18 HSPH1 SMC4 SRP72 HNRNPA1 ERLIN1 BPTF KIDINS220 DST SMC3 BAZ1A VANGL1 NFIC HGS KCTD15 RAI14 EIF3A HSPA5 DYNC1H1 CNP | 3.61e-09 | 1297 | 155 | 24 | 33545068 | |
| Pubmed | PLOD3 SRSF4 HSPA4L HSPH1 KRI1 HNRNPA1 ADD1 SMC3 HNRNPUL2 RAI14 EIF3A HSPA5 | 4.29e-09 | 274 | 155 | 12 | 34244482 | |
| Pubmed | SMARCA5 NUP107 HSPA4L HSPH1 SMC4 ADD1 ADD3 CRNKL1 TCERG1 SMC3 USP7 EIF3A NUP93 LAS1L HSPA5 DYNC1H1 CNP | 4.56e-09 | 638 | 155 | 17 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SMARCA5 SRSF4 HSPA4L HSPH1 SMC4 ATL3 KRI1 SRP72 HNRNPA1 ERLIN1 ADD1 CRNKL1 GSE1 TCERG1 SMC3 HNRNPUL2 NFRKB LTV1 EIF3A NUP93 LAS1L HSPA5 DYNC1H1 SDHA | 4.93e-09 | 1318 | 155 | 24 | 30463901 |
| Pubmed | SMARCA5 ERCC6 SRSF4 NUP107 KRT18 SMC4 KRI1 HNRNPA1 NCOA5 CRNKL1 TCERG1 SMC3 BAZ1A ZC3H4 NFIC RAI14 EIF3A NUP93 LAS1L | 8.75e-09 | 847 | 155 | 19 | 35850772 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | SRSF4 NUP107 VEZT HSPA4L SRP72 ARMCX2 HNRNPA1 TMCC3 ERLIN1 NCOA5 VPS13D DST HNRNPUL2 ZC3H4 VANGL1 PIK3R1 MTFR1 DNAJC1 ALDH1B1 HERC1 LAS1L ESPL1 METTL15 CNP SDHA | 1.25e-08 | 1496 | 155 | 25 | 32877691 |
| Pubmed | SMARCA5 NUP107 HSPH1 SRP72 HNRNPA1L2 HNRNPA1 ERLIN1 ADD1 NCOA5 BPTF CRNKL1 KIDINS220 SMC3 HNRNPUL2 EIF3A NUP93 DYNC1H1 SDHA | 1.62e-08 | 786 | 155 | 18 | 29128334 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DLG5 SMARCA5 SETX SRSF4 ERP44 SRP72 HNRNPA1 NCOA5 BPTF PPP1R10 CRNKL1 KIDINS220 DST ZBED4 TCERG1 HNRNPUL2 ZC3H4 USP7 HNRNPLL HSPA5 DYNC1H1 | 1.68e-08 | 1082 | 155 | 21 | 38697112 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | SMARCA5 KRT18 CWC27 HSPH1 KRI1 HNRNPA1 ERLIN1 NUP54 NCOA5 BPTF PPP1R10 TCERG1 SMC3 ZC3H4 NFIC USP7 EIF3A ALDH1B1 LAS1L HSPA5 | 1.94e-08 | 989 | 155 | 20 | 36424410 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | DLG5 KRT18 HSPH1 SMC4 KRI1 KIDINS220 VANGL1 BUB1B RAI14 LIMCH1 DYNC1H1 | 2.36e-08 | 256 | 155 | 11 | 33397691 |
| Pubmed | HSPA4L HSPH1 SMC4 KRI1 DST SMC3 SYNJ2 BAZ1A MTFR1 USP7 LTV1 LIMCH1 NUP93 CNP SDHA | 2.66e-08 | 547 | 155 | 15 | 37267103 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SRSF4 SMC4 SRP72 HNRNPA1 CRNKL1 DST SMC3 RAI14 EIF3A LIMCH1 NUP93 HSPA5 DYNC1H1 SDHA | 3.43e-08 | 477 | 155 | 14 | 31300519 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | NUP107 SMC4 HNRNPA1L2 BPTF TCERG1 SMC3 BAZ1A USP7 LAS1L HNRNPLL HSPA5 DYNC1H1 | 3.60e-08 | 332 | 155 | 12 | 32786267 |
| Pubmed | SMARCA5 NUP107 KRI1 SRP72 ADD1 NUP54 CRNKL1 SMARCA1 USP7 DDX60L NUP93 LAS1L | 3.60e-08 | 332 | 155 | 12 | 25693804 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SMARCA5 NUP107 KRT18 CAMK4 HSPH1 HNRNPA1 ADD1 ADD3 PPP1R10 DST GSE1 TCERG1 BAZ1A ZC3H4 BUB1B USP7 RAI14 LTV1 EIF3A | 4.11e-08 | 934 | 155 | 19 | 33916271 |
| Pubmed | PLOD3 NUP107 KRT18 VEZT PPP2R3B KRI1 NCOA5 PPP1R10 GSE1 SLC12A4 MTUS1 VANGL1 PIK3R1 HGS USP7 RAI14 NUP93 HERC1 TRIM36 HSPA5 | 5.07e-08 | 1049 | 155 | 20 | 27880917 | |
| Pubmed | SMARCA5 NUP107 KRT18 HSPA4L HSPH1 SRP72 BPTF SMC3 HNRNPUL2 USP7 PCMTD2 EIF3A NUP93 HSPA5 | 5.29e-08 | 494 | 155 | 14 | 26831064 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SMARCA5 SETX SRSF4 KRT18 KRI1 SRP72 HNRNPA1L2 SMC5 HNRNPA1 BPTF PPP1R10 CRNKL1 TCERG1 BAZ1A ZC3H4 NFRKB LAS1L TAF1L HSPA5 | 5.73e-08 | 954 | 155 | 19 | 36373674 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SMARCA5 SETX NUP107 DCUN1D5 SMC4 TRAPPC13 BPTF GSE1 ZFHX4 TCERG1 SMC3 HNRNPUL2 BAZ1A SUDS3 NFIC SMARCA1 DYNC1H1 SORL1 | 5.96e-08 | 857 | 155 | 18 | 25609649 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SMARCA5 SETX SRSF4 NUP107 KRT18 HNRNPA1 NCOA5 BPTF PPP1R10 DST ZBED4 TCERG1 BAZ1A SUDS3 NFIC NFRKB USP7 DNAJC1 NUP93 LAS1L TAF1L HSPA5 | 7.66e-08 | 1294 | 155 | 22 | 30804502 |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21738833 | ||
| Pubmed | HSPA4L HSPH1 SRP72 HNRNPA1L2 GRM1 HNRNPA1 ADD1 ADD3 KIDINS220 DST NF1 HNRNPUL2 ATP6V1D USP7 RIMBP2 RAI14 EIF3A LIMCH1 ALDH1B1 HSPA5 DYNC1H1 CNP SDHA | 1.03e-07 | 1431 | 155 | 23 | 37142655 | |
| Pubmed | 1.10e-07 | 234 | 155 | 10 | 36243803 | ||
| Pubmed | SMARCA5 KRT18 HSPA4L CWC27 HSPH1 SMC4 SRP72 HNRNPA1L2 HNRNPA1 ERLIN1 NUP54 BPTF DST SLC12A4 ZBED4 PCDHGA12 BAZ1A SMARCA1 EIF3A LIMCH1 ALDH1B1 HSPA5 EPHA4 | 1.18e-07 | 1442 | 155 | 23 | 35575683 | |
| Pubmed | 1.24e-07 | 237 | 155 | 10 | 29564676 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | SRSF4 CAMK4 HSPH1 HNRNPA1L2 HNRNPA1 ADD1 ADD3 DST ATP6V1D EIF3A DNAJC1 NUP93 HSPA5 DYNC1H1 CNP | 1.38e-07 | 621 | 155 | 15 | 22794259 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | PLOD3 ERP44 HSPA4L HSPH1 ANKRD36B DST NF1 ZC3H4 BUB1B USP7 FIBP ANKRD36 DDX60L LAS1L ESPL1 TAF1L HSPA5 EPHA4 | 1.45e-07 | 910 | 155 | 18 | 36736316 |
| Pubmed | Phospho-proteomic analyses of B-Raf protein complexes reveal new regulatory principles. | 1.55e-07 | 89 | 155 | 7 | 27034005 | |
| Pubmed | DLG5 SMARCA5 SETX HSPH1 KRI1 SRP72 ERLIN1 ADD1 ADD3 ANKRD36B PPP1R10 CRNKL1 TCERG1 BAZ1A SMARCA1 RAI14 LTV1 LIMCH1 NUP93 LAS1L DYNC1H1 CNP | 2.07e-07 | 1371 | 155 | 22 | 36244648 | |
| Pubmed | SETX NUP107 SMC4 ARMCX2 BPTF PPP1R10 CRNKL1 BAZ1A ZC3H4 SMARCA1 USP7 PCMTD2 NUP93 | 2.08e-07 | 469 | 155 | 13 | 27634302 | |
| Pubmed | SMARCA5 SRSF4 NUP107 SMC4 KRI1 SRP72 BPTF CRNKL1 DST NF1 USP7 NUP93 LAS1L DYNC1H1 SDHA | 2.62e-07 | 653 | 155 | 15 | 22586326 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 HSPA4L WNT5A HSPH1 SMC4 HNRNPA1L2 HNRNPA1 ERLIN1 POLR3B TCERG1 SMC3 ATP6V1D LTV1 EIF3A HSPA5 DYNC1H1 SDHA | 2.69e-07 | 847 | 155 | 17 | 35235311 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMARCA5 PLOD3 ERP44 KRT18 HSPA4L HSPH1 SMC4 KRI1 SRP72 HNRNPA1 CRNKL1 TCERG1 SMC3 ZC3H4 NFIC USP7 LTV1 EIF3A HSPA5 DYNC1H1 CNP SDHA | 3.53e-07 | 1415 | 155 | 22 | 28515276 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.55e-07 | 203 | 155 | 9 | 22083510 | |
| Pubmed | SMARCA5 SMC4 HNRNPA1 ADD1 PPP1R10 TCERG1 SMC3 USP7 RAI14 LIMCH1 HSPA5 | 4.10e-07 | 340 | 155 | 11 | 24332808 | |
| Pubmed | Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. | 4.51e-07 | 104 | 155 | 7 | 26167872 | |
| Pubmed | 4.53e-07 | 209 | 155 | 9 | 36779422 | ||
| Pubmed | PHLDB3 ADD1 ADD3 KIDINS220 DST VANGL1 PIK3R1 HGS RAI14 CNP SDHA EPHA4 | 4.63e-07 | 421 | 155 | 12 | 36976175 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | SMARCA5 NAB1 NUP54 BPTF GSE1 ZFHX4 BAZ1A SUDS3 NFIC NFRKB SMARCA1 | 5.61e-07 | 351 | 155 | 11 | 38297188 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | SMARCA5 KRT18 KRI1 SRP72 HNRNPA1 NCOA5 ZFHX4 SMC3 HNRNPUL2 BAZ1A SMARCA1 EIF3A LAS1L HSPA5 | 6.13e-07 | 605 | 155 | 14 | 28977666 |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 6.70e-07 | 219 | 155 | 9 | 31353912 | |
| Pubmed | SMARCA5 SMC4 SMC5 NCOA5 BPTF PPP1R10 CRNKL1 POLR3B TCERG1 SMC3 HNRNPUL2 BAZ1A SUDS3 NFIC USP7 EIF3A NUP93 HNRNPLL | 6.99e-07 | 1014 | 155 | 18 | 32416067 | |
| Pubmed | SLC9A8 SRSF4 DCUN1D5 HSPH1 SMC4 KRI1 SRP72 HNRNPA1 NCOA5 PPP1R10 SMC3 USP7 EIF3A HSPA5 DYNC1H1 SDHA | 7.49e-07 | 809 | 155 | 16 | 32129710 | |
| Pubmed | DOCK1 DOCK2 SMARCA5 SRSF4 ERP44 HSPA4L PPP2R3B SMC4 ERLIN1 PPP1R10 TCERG1 SMC3 PIK3R1 USP7 NUP93 SDHA SORL1 | 7.94e-07 | 916 | 155 | 17 | 32203420 | |
| Pubmed | DLG5 PLOD3 NUP107 VEZT HSPA4L HSPH1 KRI1 HNRNPA1 TMCC3 ADD1 ADD3 KIDINS220 VANGL1 PIK3R1 HGS BUB1B LTV1 DNAJC1 LAS1L ESPL1 HSPA5 SDHA | 8.08e-07 | 1487 | 155 | 22 | 33957083 | |
| Pubmed | 9.36e-07 | 228 | 155 | 9 | 30471916 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | SMARCA5 KRI1 SRP72 ADD1 ADD3 BPTF BAZ1A LAS1L TAF1L HNRNPLL DYNC1H1 | 9.40e-07 | 370 | 155 | 11 | 22922362 |
| Pubmed | HSPH1 KRI1 HNRNPA1 MSTO1 ERLIN1 SMC3 HNRNPUL2 SMARCA1 LTV1 NUP93 ALDH1B1 HSPA5 DYNC1H1 CNP SDHA | 9.71e-07 | 725 | 155 | 15 | 27025967 | |
| Pubmed | PLOD3 HSPA4L HSPH1 TMTC2 ERLIN1 PPP1R10 DST HNRNPUL2 PIK3R1 HGS USP7 RAI14 LAS1L CNP | 1.06e-06 | 634 | 155 | 14 | 34591612 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ERP44 NUP107 KRT18 VEZT HSPA4L TM9SF1 HSPH1 SMC4 SRP72 ERLIN1 KIDINS220 SMC3 LTV1 NUP93 ESPL1 DYNC1H1 SDHA | 1.16e-06 | 942 | 155 | 17 | 31073040 |
| Pubmed | SMARCA5 SMC4 ADD1 ADD3 BPTF PPP1R10 TCERG1 BUB1B NFRKB USP7 RAI14 HSPA5 DYNC1H1 | 1.22e-06 | 549 | 155 | 13 | 38280479 | |
| Pubmed | DOCK2 NUP107 HLA-DPB1 HLA-DRB1 ATL3 HNRNPA1 ITGB7 KIDINS220 NF1 HNRNPUL2 PIK3R1 EIF3A DNAJC1 NUP93 LAS1L HNRNPLL HSPA5 DYNC1H1 CNP | 1.23e-06 | 1168 | 155 | 19 | 19946888 | |
| Pubmed | FOLH1 HLA-DRB1 HSPH1 JAKMIP3 MSTO1 ADD3 CRNKL1 POLR3B DST TCERG1 PIK3R1 USP7 FIBP RAI14 PCMTD2 ANKRD36 ZNF841 HSPA5 DYNC1H1 SDHA | 1.24e-06 | 1285 | 155 | 20 | 35914814 | |
| Pubmed | 1.38e-06 | 43 | 155 | 5 | 26030138 | ||
| Pubmed | 1.70e-06 | 245 | 155 | 9 | 35652658 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | SMARCA5 ERCC6 KRI1 SRP72 SMC5 NCOA5 BPTF POLR3B TCERG1 SMC3 HNRNPUL2 BAZ1A LTV1 LAS1L ESPL1 | 1.71e-06 | 759 | 155 | 15 | 35915203 |
| Pubmed | WSTF-ISWI chromatin remodeling complex targets heterochromatic replication foci. | 1.72e-06 | 6 | 155 | 3 | 11980720 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | HSPH1 PPP2R3B PPP1R10 SUDS3 VANGL1 PHACTR3 RAI14 EIF3A NUP93 HERC1 LAS1L DYNC1H1 SDHA | 1.95e-06 | 573 | 155 | 13 | 28330616 |
| Pubmed | TM9SF1 HSPH1 DST SLC12A4 SMC3 BAZ1A EIF3A ESPL1 HSPA5 DYNC1H1 | 2.02e-06 | 322 | 155 | 10 | 26514267 | |
| Pubmed | DENND5B TRAF5 HSPH1 SMC5 HNRNPA1 MSTO1 NCOA5 TRAPPC13 NF1 SLC12A4 ZBED4 SMC3 SUDS3 COQ4 NFRKB USP7 FIBP LAS1L MAGEB17 HSPA5 | 2.03e-06 | 1327 | 155 | 20 | 32694731 | |
| Pubmed | DOCK1 SETX KRT18 NUP54 DST TCERG1 SMC3 SYNJ2 PIK3R1 HGS EIF3A HSPA5 | 2.07e-06 | 486 | 155 | 12 | 20936779 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | SRSF4 SMC4 HNRNPA1 SMC3 ZC3H4 PIK3R1 USP7 LTV1 EIF3A ALDH1B1 HSPA5 CNP | 2.07e-06 | 486 | 155 | 12 | 30940648 |
| Pubmed | SETX NUP107 CAMK4 HNRNPA1 ADD1 ADD3 KIDINS220 DST ZC3H4 VANGL1 MTFR1 RAI14 HNRNPLL ZMAT1 DYNC1H1 | 2.27e-06 | 777 | 155 | 15 | 35844135 | |
| Pubmed | SMARCA5 ERCC6 NUP107 VEZT FAT3 BPTF GSE1 ZFHX4 MTUS1 SUDS3 ZC3H4 VANGL1 PIK3R1 NFRKB SMARCA1 USP7 FIBP SORL1 | 2.70e-06 | 1116 | 155 | 18 | 31753913 | |
| Pubmed | 3.03e-06 | 263 | 155 | 9 | 34702444 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 3.36e-06 | 341 | 155 | 10 | 32971831 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | SMARCA5 SETX ERCC6 DCUN1D5 CWC27 BPTF PPP1R10 SMC3 BAZ1A NFIC NFRKB SMARCA1 USP7 | 3.72e-06 | 608 | 155 | 13 | 36089195 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SMARCA5 HNRNPA1L2 HNRNPA1 BPTF TCERG1 SMARCA1 EIF3A LAS1L HSPA5 | 3.87e-06 | 271 | 155 | 9 | 32433965 |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | SMARCA5 HSPA4L HSPH1 HNRNPA1 NCOA5 SMC3 HNRNPUL2 BAZ1A SMARCA1 HSPA5 SDHA | 3.99e-06 | 430 | 155 | 11 | 38172120 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SRSF4 KRT18 HSPA4L HSPH1 SMC4 HNRNPA1 ADD1 DST TCERG1 SMC3 ZC3H4 USP7 RAI14 EIF3A LIMCH1 NUP93 HSPA5 DYNC1H1 | 4.04e-06 | 1149 | 155 | 18 | 35446349 |
| Pubmed | SMARCA5 SRSF4 KRT18 HSPA4L CWC27 HSPH1 SMC4 KRI1 SRP72 HNRNPA1L2 HNRNPA1 SMC3 HNRNPUL2 LTV1 EIF3A ALDH1B1 HSPA5 DYNC1H1 | 4.24e-06 | 1153 | 155 | 18 | 29845934 | |
| Pubmed | 4.78e-06 | 8 | 155 | 3 | 16330189 | ||
| Pubmed | A chromatin remodelling complex that loads cohesin onto human chromosomes. | 4.78e-06 | 8 | 155 | 3 | 12198550 | |
| Pubmed | Inhibition of N-glycan processing modulates the network of EDEM3 interactors. | 5.72e-06 | 57 | 155 | 5 | 28366632 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 6.33e-06 | 217 | 155 | 8 | 31685992 | |
| Pubmed | 6.36e-06 | 101 | 155 | 6 | 26949739 | ||
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 7.15e-06 | 9 | 155 | 3 | 16728976 | |
| Pubmed | HSPA4L HSPH1 SMC4 KRI1 SRP72 HNRNPA1L2 PPP1R10 CRNKL1 ZC3H4 BUB1B USP7 LTV1 EIF3A HSPA5 SDHA CDH18 | 7.69e-06 | 971 | 155 | 16 | 33306668 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 SETX KRT18 REEP3 TMCC3 VPS13D DST NF1 TCERG1 MTUS1 SYNJ2 BUB1B RAI14 LIMCH1 NUP93 | 7.80e-06 | 861 | 155 | 15 | 36931259 |
| Pubmed | 7.95e-06 | 105 | 155 | 6 | 9628581 | ||
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 8.11e-06 | 377 | 155 | 10 | 38117590 | |
| Pubmed | Ubiquitin-Activated Interaction Traps (UBAITs) identify E3 ligase binding partners. | 8.69e-06 | 62 | 155 | 5 | 26508657 | |
| Pubmed | DOCK2 SETX HSPH1 NCF1 NAB1 SMC4 SRP72 HNRNPA1 BPTF GSE1 TCERG1 SMC3 NFIC NFRKB NUP93 HNRNPLL DYNC1H1 | 9.41e-06 | 1103 | 155 | 17 | 34189442 | |
| Pubmed | VEZT HSPH1 ATL3 SRP72 VPS13D DST SLC12A4 VANGL1 MTFR1 RAI14 LIMCH1 DNAJC1 | 1.00e-05 | 568 | 155 | 12 | 37774976 | |
| Interaction | FOXL1 interactions | SMARCA5 NUP107 DCUN1D5 SMC4 GSE1 ZFHX4 SMC3 HNRNPUL2 BAZ1A NFIC SMARCA1 USP7 DYNC1H1 | 3.40e-09 | 196 | 153 | 13 | int:FOXL1 |
| Interaction | KCNA3 interactions | DOCK1 DLG5 HSPA4L HSPH1 SMC4 SRP72 HNRNPA1 ERLIN1 ADD1 MYO5C KIDINS220 DST TCERG1 SMC3 VANGL1 HGS BUB1B RAI14 LTV1 HSPA5 DYNC1H1 CNP SDHA SORL1 | 4.27e-08 | 871 | 153 | 24 | int:KCNA3 |
| Interaction | BRCA1 interactions | SMARCA5 SETX PLOD3 ERCC6 NUP107 KRT18 HSPA4L HSPH1 SRP72 SMC5 HNRNPA1 ERLIN1 GOLGA8DP BPTF DST NF1 SMC3 HNRNPUL2 NFIC PIK3R1 USP7 CCNA1 PCMTD2 EIF3A NUP93 HERC1 TRIM36 HSPA5 DYNC1H1 | 5.94e-08 | 1249 | 153 | 29 | int:BRCA1 |
| Interaction | CDC5L interactions | SMARCA5 SETX SRSF4 NUP107 KRT18 CWC27 SMC4 SRP72 SMC5 HNRNPA1 CRNKL1 DST NF1 GSE1 SMC3 HNRNPUL2 BUB1B USP7 NUP93 LAS1L HNRNPLL HSPA5 DYNC1H1 | 1.30e-07 | 855 | 153 | 23 | int:CDC5L |
| Interaction | EED interactions | SMARCA5 SETX PLOD3 NUP107 KRT18 HSPH1 SMC4 SMC5 HNRNPA1 ITGB7 NCOA5 BPTF CRNKL1 TCERG1 SMC3 HNRNPUL2 BAZ1A SUDS3 SNX7 TTC21B SMARCA1 USP7 RAI14 EIF3A LIMCH1 NUP93 LAS1L HNRNPLL HSPA5 DYNC1H1 | 3.84e-07 | 1445 | 153 | 30 | int:EED |
| Interaction | CIT interactions | SMARCA5 SETX ERP44 NUP107 SMC4 KRI1 SRP72 HNRNPA1L2 HNRNPA1 ERLIN1 NUP54 NCOA5 BPTF CRNKL1 TCERG1 SMC3 HNRNPUL2 HGS SMARCA1 RAI14 EIF3A DDX60L NUP93 HERC1 LAS1L GRAMD1C HNRNPLL HSPA5 DYNC1H1 SDHA | 4.13e-07 | 1450 | 153 | 30 | int:CIT |
| Interaction | IFI16 interactions | SMARCA5 SRSF4 NUP107 HSPA4L HSPH1 KRI1 SRP72 HNRNPA1L2 HNRNPA1 ADD1 NUP54 CRNKL1 SMARCA1 USP7 RAI14 EIF3A DDX60L NUP93 LAS1L HSPA5 | 4.96e-07 | 714 | 153 | 20 | int:IFI16 |
| Interaction | CIC interactions | SMARCA5 NUP107 HSPA4L HSPH1 SMC5 ADD1 ZFHX4 ZBED4 TCERG1 SMC3 BAZ1A SUDS3 NFIC HGS USP7 EIF3A HSPA5 CNP SDHA | 8.74e-07 | 673 | 153 | 19 | int:CIC |
| Interaction | FGFR3 interactions | SMARCA5 VEZT HSPA4L KRI1 SMC3 HNRNPUL2 BAZ1A PIK3R1 HGS NUP93 DYNC1H1 CNP EPHA4 | 8.76e-07 | 315 | 153 | 13 | int:FGFR3 |
| Interaction | CHD3 interactions | SMARCA5 SETX HSPH1 KRI1 SRP72 SMC5 HNRNPA1 NCOA5 BPTF GSE1 ZFHX4 TCERG1 SMC3 HNRNPUL2 BAZ1A SUDS3 SMARCA1 EIF3A LAS1L HSPA5 | 1.23e-06 | 757 | 153 | 20 | int:CHD3 |
| Interaction | DUXA interactions | 1.51e-06 | 12 | 153 | 4 | int:DUXA | |
| Interaction | TNIP1 interactions | DLG5 SMARCA5 ERP44 KRT18 CACNA2D2 HSPH1 SMC4 SRP72 HNRNPA1L2 HNRNPA1 MYO5C CRNKL1 DST TCERG1 SMC3 HNRNPUL2 PIK3R1 USP7 RAI14 EIF3A LIMCH1 NUP93 LAS1L HSPA5 DYNC1H1 SDHA | 1.54e-06 | 1217 | 153 | 26 | int:TNIP1 |
| Interaction | RHOH interactions | DLG5 ERLIN1 ADD1 ADD3 VPS13D KIDINS220 DST SLC12A4 HNRNPUL2 VANGL1 PIK3R1 USP7 FIBP RAI14 CNP SORL1 | 1.86e-06 | 512 | 153 | 16 | int:RHOH |
| Interaction | MAPRE1 interactions | DLG5 ERCC6 NUP107 VEZT ADD1 ADD3 NUP54 DST MTUS1 HNRNPUL2 SYNJ2 EIF3A NUP93 TRIM36 HSPA5 DYNC1H1 | 1.95e-06 | 514 | 153 | 16 | int:MAPRE1 |
| Interaction | TEK interactions | 3.53e-06 | 119 | 153 | 8 | int:TEK | |
| Interaction | FBXO22 interactions | SMARCA5 PLOD3 ERCC6 HSPA4L HSPH1 SMC4 SMC5 PPP1R10 CRNKL1 VPS13D SMC3 ZC3H4 USP7 RAI14 LIMCH1 HERC1 | 3.68e-06 | 540 | 153 | 16 | int:FBXO22 |
| Interaction | NUPR1 interactions | SMARCA5 PLOD3 SRSF4 NUP107 KRT18 CWC27 HNRNPA1 NUP54 DST TCERG1 SMC3 HNRNPUL2 BAZ1A SMARCA1 USP7 EIF3A NUP93 CNP | 4.53e-06 | 683 | 153 | 18 | int:NUPR1 |
| Interaction | C9orf78 interactions | SMARCA5 NUP107 CWC27 HSPH1 SMC4 ADD1 NUP54 PPP1R10 POLR3B TCERG1 SMC3 BAZ1A NUP93 LAS1L HSPA5 DYNC1H1 SDHA | 5.05e-06 | 620 | 153 | 17 | int:C9orf78 |
| Interaction | RYK interactions | WNT5A FAT3 KIDINS220 DST PCDHGA12 VANGL1 HGS NUP93 DYNC1H1 EPHA4 | 5.21e-06 | 212 | 153 | 10 | int:RYK |
| Interaction | HECTD1 interactions | SMARCA5 ERCC6 KRT18 HSPA4L HSPH1 SMC4 KRI1 SRP72 SMC5 MYO5C NCOA5 BPTF POLR3B TCERG1 SMC3 HNRNPUL2 BAZ1A LTV1 NUP93 LAS1L ESPL1 METTL15 | 5.31e-06 | 984 | 153 | 22 | int:HECTD1 |
| Interaction | FOXP3 interactions | SMARCA5 NUP107 KRI1 SRP72 HNRNPA1 ADD1 ADD3 BPTF SMC3 BAZ1A USP7 LAS1L HNRNPLL DYNC1H1 | 5.60e-06 | 432 | 153 | 14 | int:FOXP3 |
| Interaction | GLDC interactions | PLOD3 SRSF4 HSPA4L HSPH1 KRI1 HNRNPA1 ADD1 SMC3 HNRNPUL2 RAI14 EIF3A HSPA5 | 6.46e-06 | 321 | 153 | 12 | int:GLDC |
| Interaction | ERCC6 interactions | SMARCA5 ERCC6 HNRNPA1L2 HNRNPA1 CRNKL1 HNRNPUL2 SMARCA1 USP7 HSPA5 SDHA | 8.46e-06 | 224 | 153 | 10 | int:ERCC6 |
| Interaction | SUMO2 interactions | SETX ERCC6 NUP107 SMC4 HNRNPA1L2 SMC5 BPTF DST TCERG1 SMC3 BAZ1A USP7 LAS1L HNRNPLL HSPA5 DYNC1H1 | 1.14e-05 | 591 | 153 | 16 | int:SUMO2 |
| Interaction | KPNA1 interactions | SMARCA5 CAMK4 NUP54 BPTF POLR3B ZFHX4 TCERG1 BAZ1A SUDS3 SMARCA1 USP7 LIMCH1 | 1.58e-05 | 351 | 153 | 12 | int:KPNA1 |
| Interaction | NAA40 interactions | SMARCA5 NUP107 KRT18 CAMK4 HSPH1 SMC5 HNRNPA1 ADD1 ADD3 PPP1R10 DST GSE1 TCERG1 BAZ1A ZC3H4 BUB1B USP7 RAI14 LTV1 EIF3A LIMCH1 | 1.63e-05 | 978 | 153 | 21 | int:NAA40 |
| Interaction | SMARCA5 interactions | SMARCA5 ERCC6 SMC4 SMC5 BPTF POLR3B SMC3 BAZ1A SUDS3 SMARCA1 USP7 NUP93 HSPA5 | 1.75e-05 | 415 | 153 | 13 | int:SMARCA5 |
| Interaction | RND1 interactions | DLG5 ADD3 KIDINS220 DST SLC12A4 VANGL1 PIK3R1 USP7 RAI14 CNP | 1.91e-05 | 246 | 153 | 10 | int:RND1 |
| Interaction | NR2C2 interactions | SMARCA5 SRSF4 HSPA4L HSPH1 SMC4 ATL3 KRI1 SRP72 SMC5 HNRNPA1 ERLIN1 ADD1 CRNKL1 GSE1 TCERG1 SMC3 HNRNPUL2 NFIC NFRKB LTV1 EIF3A NUP93 LAS1L HSPA5 DYNC1H1 SDHA | 1.97e-05 | 1403 | 153 | 26 | int:NR2C2 |
| Interaction | EZR interactions | DLG5 NUP107 HSPA4L HSPH1 SRP72 HNRNPA1L2 ADD3 MYO5C KIDINS220 DST VANGL1 PIK3R1 HGS RAI14 LIMCH1 | 2.13e-05 | 553 | 153 | 15 | int:EZR |
| Interaction | BIRC3 interactions | SMARCA5 ERP44 NUP107 CACNA2D2 HSPA4L HSPH1 SMC4 KRI1 SRP72 HNRNPA1 NCOA5 CRNKL1 NF1 TCERG1 SMC3 HNRNPUL2 BAZ1A SNX7 USP7 EIF3A NUP93 ALDH1B1 HSPA5 DYNC1H1 SDHA | 2.41e-05 | 1334 | 153 | 25 | int:BIRC3 |
| Interaction | C11orf52 interactions | DLG5 ADD1 ADD3 KIDINS220 DST VANGL1 PIK3R1 HGS RAI14 NUP93 CNP | 2.65e-05 | 311 | 153 | 11 | int:C11orf52 |
| Interaction | YAP1 interactions | SMARCA5 ERP44 HSPA4L CWC27 HSPH1 LAIR2 SMC4 HNRNPA1L2 HNRNPA1 ADD1 ADD3 BPTF PPP1R10 NF1 TCERG1 BUB1B NFRKB USP7 RAI14 EIF3A HSPA5 DYNC1H1 | 2.79e-05 | 1095 | 153 | 22 | int:YAP1 |
| Interaction | CHD4 interactions | SMARCA5 ERCC6 KRT18 NAB1 SMC4 KRI1 SMC5 HNRNPA1 NCOA5 BPTF CRNKL1 GSE1 ZFHX4 SMC3 HNRNPUL2 SUDS3 SMARCA1 EIF3A LAS1L HSPA5 | 2.92e-05 | 938 | 153 | 20 | int:CHD4 |
| Interaction | NTRK3 interactions | ERP44 VEZT HSPA4L HSPH1 ERLIN1 KIDINS220 VANGL1 SNX7 PIK3R1 HGS USP7 HSPA5 | 2.95e-05 | 374 | 153 | 12 | int:NTRK3 |
| Interaction | DIRAS3 interactions | 3.27e-05 | 262 | 153 | 10 | int:DIRAS3 | |
| Interaction | RBBP7 interactions | SMARCA5 ERCC6 NCF1 SMC4 SMC5 MSTO1 BPTF GSE1 SMC3 HNRNPUL2 BAZ1A SUDS3 SMARCA1 HSPA5 | 3.34e-05 | 507 | 153 | 14 | int:RBBP7 |
| Interaction | FOXE1 interactions | 3.52e-05 | 81 | 153 | 6 | int:FOXE1 | |
| Interaction | WDR76 interactions | SMARCA5 PLOD3 KRT18 HSPA4L CWC27 HSPH1 SMC4 PPP1R10 SMC3 USP7 HNRNPLL HSPA5 | 3.72e-05 | 383 | 153 | 12 | int:WDR76 |
| Interaction | MECP2 interactions | DLG5 SMARCA5 SETX SRSF4 ERP44 SRP72 SMC5 HNRNPA1 NCOA5 BPTF PPP1R10 CRNKL1 KIDINS220 DST ZBED4 TCERG1 SMC3 HNRNPUL2 BAZ1A ZC3H4 USP7 HNRNPLL HSPA5 DYNC1H1 | 3.88e-05 | 1287 | 153 | 24 | int:MECP2 |
| Interaction | FBXL6 interactions | HSPA4L HSPH1 SMC4 KRI1 DST SMC3 SYNJ2 BAZ1A MTFR1 USP7 LTV1 LIMCH1 NUP93 CNP SDHA | 3.91e-05 | 583 | 153 | 15 | int:FBXL6 |
| Interaction | DOT1L interactions | SMARCA5 ERCC6 SRSF4 KRT18 SMC4 KRI1 HNRNPA1 NCOA5 CRNKL1 TCERG1 SMC3 BAZ1A ZC3H4 NFIC RAI14 EIF3A NUP93 LAS1L | 4.23e-05 | 807 | 153 | 18 | int:DOT1L |
| Interaction | CGAS interactions | SMARCA5 HSPA4L HSPH1 SRP72 SLC12A4 SMARCA1 USP7 RAI14 LTV1 DDX60L CNP | 4.42e-05 | 329 | 153 | 11 | int:CGAS |
| Interaction | FLT4 interactions | SMARCA5 VEZT HSPA4L HSPH1 SMC3 PIK3R1 NUP93 HSPA5 DYNC1H1 CNP | 4.49e-05 | 272 | 153 | 10 | int:FLT4 |
| Interaction | PHLPP1 interactions | DLG5 KRT18 HSPH1 SMC4 KRI1 KIDINS220 VANGL1 BUB1B RAI14 LIMCH1 DYNC1H1 | 4.93e-05 | 333 | 153 | 11 | int:PHLPP1 |
| Interaction | RBMX interactions | ERCC6 SRSF4 KRT18 HSPA4L HNRNPA1L2 SMC5 HNRNPA1 NCOA5 VPS13D P3H2 USP7 METTL15 DYNC1H1 | 5.20e-05 | 461 | 153 | 13 | int:RBMX |
| Interaction | KHDRBS2 interactions | 5.84e-05 | 129 | 153 | 7 | int:KHDRBS2 | |
| Interaction | TPR interactions | 5.89e-05 | 281 | 153 | 10 | int:TPR | |
| Interaction | EPHA7 interactions | SLC9A8 PLOD3 ERP44 WNT5A HSPH1 PIK3R1 HGS HSPA5 IL17RB EPHA4 | 6.07e-05 | 282 | 153 | 10 | int:EPHA7 |
| Interaction | NTRK2 interactions | 6.09e-05 | 176 | 153 | 8 | int:NTRK2 | |
| Interaction | PINK1 interactions | SRSF4 SMC4 APCS SRP72 HNRNPA1 ERLIN1 CRNKL1 DST SMC3 RAI14 EIF3A LIMCH1 NUP93 HSPA5 DYNC1H1 SDHA | 6.10e-05 | 679 | 153 | 16 | int:PINK1 |
| Interaction | TEAD2 interactions | 6.13e-05 | 130 | 153 | 7 | int:TEAD2 | |
| Interaction | NUMA1 interactions | SMARCA5 NUP107 HSPA4L HNRNPA1L2 SMC5 HNRNPA1 NUP54 SMC3 BAZ1A SMARCA1 USP7 NUP93 DYNC1H1 | 6.19e-05 | 469 | 153 | 13 | int:NUMA1 |
| Interaction | MTA1 interactions | SMARCA5 ERCC6 SMC5 BPTF GSE1 SMC3 BAZ1A SUDS3 SMARCA1 DYNC1H1 | 6.25e-05 | 283 | 153 | 10 | int:MTA1 |
| Interaction | G3BP1 interactions | SMARCA5 SRSF4 KRT18 SMC4 KRI1 SMC5 HNRNPA1 ADD3 NUP54 PPP1R10 DST PHACTR3 SMARCA1 LTV1 EIF3A NUP93 HSPA5 DYNC1H1 | 6.56e-05 | 835 | 153 | 18 | int:G3BP1 |
| Interaction | CEBPA interactions | DOCK2 SETX NUP107 HSPH1 NCF1 NAB1 SMC4 SRP72 HNRNPA1 NCOA5 TGFB2 BPTF GSE1 TCERG1 SMC3 HNRNPUL2 BAZ1A NFIC NFRKB NUP93 HNRNPLL HSPA5 DYNC1H1 | 6.62e-05 | 1245 | 153 | 23 | int:CEBPA |
| Interaction | SSRP1 interactions | SMARCA5 SETX SMC5 HNRNPA1 NCOA5 PPP1R10 CRNKL1 TCERG1 HNRNPUL2 ZC3H4 PIK3R1 SMARCA1 EIF3A NUP93 HSPA5 SDHA | 6.77e-05 | 685 | 153 | 16 | int:SSRP1 |
| Interaction | FLOT1 interactions | DLG5 ADD1 ADD3 KIDINS220 DST NF1 SLC12A4 VANGL1 PIK3R1 HGS RAI14 HSPA5 SDHA | 7.04e-05 | 475 | 153 | 13 | int:FLOT1 |
| Interaction | SMC5 interactions | SMARCA5 SETX SRSF4 KRT18 KRI1 SRP72 HNRNPA1L2 SMC5 HNRNPA1 BPTF PPP1R10 CRNKL1 TCERG1 SMC3 BAZ1A ZC3H4 NFRKB LAS1L TAF1L HSPA5 | 7.12e-05 | 1000 | 153 | 20 | int:SMC5 |
| Interaction | MTNR1B interactions | 7.79e-05 | 135 | 153 | 7 | int:MTNR1B | |
| Interaction | RAE1 interactions | 8.22e-05 | 236 | 153 | 9 | int:RAE1 | |
| Interaction | ZBBX interactions | 8.57e-05 | 31 | 153 | 4 | int:ZBBX | |
| Interaction | FOXG1 interactions | 8.65e-05 | 95 | 153 | 6 | int:FOXG1 | |
| Interaction | SAMD9L interactions | 8.98e-05 | 12 | 153 | 3 | int:SAMD9L | |
| Interaction | DLST interactions | DLG5 SMARCA5 NCF1 HNRNPA1L2 NCOA5 BPTF CRNKL1 USP7 NUP93 METTL15 HSPA5 DYNC1H1 SDHA | 9.62e-05 | 490 | 153 | 13 | int:DLST |
| Interaction | EPB41L4A interactions | 9.79e-05 | 140 | 153 | 7 | int:EPB41L4A | |
| Interaction | FOXQ1 interactions | 1.02e-04 | 141 | 153 | 7 | int:FOXQ1 | |
| Interaction | HTT interactions | SRSF4 CAMK4 HSPH1 GRM1 HNRNPA1 ADD1 ADD3 PPP1R10 DST TCERG1 PIK3R1 ATP6V1D HGS EIF3A DNAJC1 NUP93 HSPA5 DYNC1H1 CNP | 1.08e-04 | 949 | 153 | 19 | int:HTT |
| Interaction | MYL12A interactions | 1.12e-04 | 192 | 153 | 8 | int:MYL12A | |
| Interaction | EPHA2 interactions | PHLDB3 DLG5 GRM1 ADD1 ADD3 KIDINS220 DST NF1 VANGL1 NFIC PIK3R1 HGS RAI14 CNP SDHA EPHA4 | 1.19e-04 | 719 | 153 | 16 | int:EPHA2 |
| Interaction | SUZ12 interactions | SMARCA5 SETX NUP107 SMC4 SMC5 ERLIN1 BPTF CRNKL1 NF1 SMC3 SUDS3 SMARCA1 USP7 NUP93 DYNC1H1 | 1.19e-04 | 644 | 153 | 15 | int:SUZ12 |
| Interaction | COL17A1 interactions | 1.24e-04 | 34 | 153 | 4 | int:COL17A1 | |
| Interaction | RHOU interactions | DLG5 PLOD3 ADD1 ADD3 KIDINS220 DST SLC12A4 VANGL1 PIK3R1 HGS RAI14 CNP EPHA4 | 1.43e-04 | 510 | 153 | 13 | int:RHOU |
| Interaction | RHOQ interactions | DLG5 ADD1 ADD3 KIDINS220 DST NF1 SLC12A4 VANGL1 PIK3R1 FIBP RAI14 CNP | 1.45e-04 | 442 | 153 | 12 | int:RHOQ |
| Interaction | CCDC8 interactions | SMARCA5 KRT18 SMC4 HNRNPA1 MYO5C DST NF1 SMC3 BAZ1A VANGL1 EIF3A NUP93 HSPA5 DYNC1H1 CNP | 1.46e-04 | 656 | 153 | 15 | int:CCDC8 |
| Interaction | MST1R interactions | 1.48e-04 | 200 | 153 | 8 | int:MST1R | |
| Interaction | SYNE3 interactions | DLG5 PLOD3 ERP44 NUP107 VEZT TMCC3 KIDINS220 DST GSE1 HGS DNAJC1 HSPA5 | 1.51e-04 | 444 | 153 | 12 | int:SYNE3 |
| Interaction | BMI1 interactions | DLG5 SMARCA5 SRSF4 NCOA5 TRAPPC13 CRNKL1 DST BAZ1A ZC3H4 NFIC USP7 LTV1 NUP93 LAS1L DYNC1H1 | 1.53e-04 | 659 | 153 | 15 | int:BMI1 |
| Interaction | ARMC5 interactions | 1.53e-04 | 201 | 153 | 8 | int:ARMC5 | |
| Interaction | METTL21A interactions | 1.56e-04 | 36 | 153 | 4 | int:METTL21A | |
| Interaction | POLE3 interactions | 1.59e-04 | 106 | 153 | 6 | int:POLE3 | |
| Interaction | LTK interactions | 1.63e-04 | 152 | 153 | 7 | int:LTK | |
| Interaction | TPX2 interactions | 1.70e-04 | 204 | 153 | 8 | int:TPX2 | |
| Interaction | C20orf173 interactions | 1.71e-04 | 3 | 153 | 2 | int:C20orf173 | |
| Interaction | CHAF1A interactions | SMARCA5 HSPH1 SMC5 BPTF TCERG1 SUDS3 PIK3R1 SMARCA1 EIF3A LAS1L | 1.80e-04 | 322 | 153 | 10 | int:CHAF1A |
| Interaction | FGD5 interactions | 1.88e-04 | 207 | 153 | 8 | int:FGD5 | |
| Interaction | EPHA3 interactions | 2.04e-04 | 111 | 153 | 6 | int:EPHA3 | |
| Interaction | CDC14A interactions | 2.04e-04 | 111 | 153 | 6 | int:CDC14A | |
| Interaction | CDC34 interactions | 2.09e-04 | 328 | 153 | 10 | int:CDC34 | |
| Interaction | FZR1 interactions | HSPA4L HSPH1 SMC4 KRI1 SRP72 HNRNPA1L2 HNRNPA1 PPP1R10 CRNKL1 HNRNPUL2 ZC3H4 BUB1B USP7 CCNA1 LTV1 EIF3A LAS1L HSPA5 SDHA CDH18 EPHA4 | 2.15e-04 | 1172 | 153 | 21 | int:FZR1 |
| Interaction | LCK interactions | PHLDB3 DLG5 ITGB7 KIDINS220 DST NF1 VANGL1 PIK3R1 USP7 RAI14 HSPA5 CNP | 2.23e-04 | 463 | 153 | 12 | int:LCK |
| Interaction | INHA interactions | 2.23e-04 | 16 | 153 | 3 | int:INHA | |
| Interaction | CEBPB interactions | DOCK2 SMARCA5 SRSF4 HSPH1 SMC4 SRP72 HNRNPA1 BPTF CRNKL1 TCERG1 MTUS1 SMC3 BAZ1A ZC3H4 NFIC USP7 EIF3A NUP93 ALDH1B1 LAS1L HSPA5 DYNC1H1 CNP SDHA | 2.26e-04 | 1443 | 153 | 24 | int:CEBPB |
| Interaction | GSK3A interactions | DLG5 SMARCA5 ADD1 ADD3 VPS13D POLR3B KIDINS220 DST MTUS1 LTV1 EIF3A HSPA5 | 2.27e-04 | 464 | 153 | 12 | int:GSK3A |
| Interaction | STIP1 interactions | SMARCA5 NUP107 HSPA4L HSPH1 SMC4 HNRNPA1 ADD1 ADD3 CRNKL1 TCERG1 SMC3 USP7 EIF3A NUP93 ALDH1B1 LAS1L HSPA5 DYNC1H1 CNP | 2.28e-04 | 1006 | 153 | 19 | int:STIP1 |
| Interaction | MBD2 interactions | 2.33e-04 | 161 | 153 | 7 | int:MBD2 | |
| Interaction | USP11 interactions | SETX HSPA4L HSPH1 SRP72 ADD1 ADD3 USP7 EIF3A ALDH1B1 ESPL1 HSPA5 DYNC1H1 SDHA | 2.45e-04 | 539 | 153 | 13 | int:USP11 |
| Interaction | RND3 interactions | 2.46e-04 | 273 | 153 | 9 | int:RND3 | |
| Interaction | PTEN interactions | SMARCA5 SETX HSPA4L HSPH1 NCF1 SMC4 HNRNPA1 ITGB7 ADD3 TRAPPC13 PPP1R10 NF1 SMC3 SUDS3 PIK3R1 USP7 LTV1 ALDH1B1 | 2.48e-04 | 929 | 153 | 18 | int:PTEN |
| Interaction | CHRAC1 interactions | 2.50e-04 | 74 | 153 | 5 | int:CHRAC1 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 6.18e-06 | 7 | 103 | 3 | 761 | |
| GeneFamily | Transmembrane and coiled-coil domain containing | 9.61e-05 | 3 | 103 | 2 | 774 | |
| GeneFamily | Heat shock 70kDa proteins | 1.15e-04 | 17 | 103 | 3 | 583 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 4.75e-04 | 6 | 103 | 2 | 1181 | |
| GeneFamily | Nucleoporins | 7.90e-04 | 32 | 103 | 3 | 1051 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DOCK1 SMARCA5 SETX WNT5A SMC5 DCUN1D4 TGFB2 BPTF KIDINS220 DST GSE1 SMC3 SYNJ2 BAZ1A ZC3H4 MTFR1 BUB1B SMARCA1 USP7 EIF3A EPHA4 FILIP1L | 6.52e-09 | 856 | 154 | 22 | M4500 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | SETX HSPA4L CWC27 HSPH1 SMC4 ADD3 TRAPPC13 BPTF BMP7 KIDINS220 MTUS1 SMC3 BAZ1A BUB1B RAI14 EIF3A DNAJC1 SORL1 | 6.56e-08 | 656 | 154 | 18 | M18979 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | DLG5 SMARCA5 TRAF5 PLOD3 HLA-DPB1 HLA-DRB1 HSPH1 HNRNPA1 TRAPPC13 PPP1R10 NF1 TCERG1 BAZ1A MTFR1 RAI14 SDHA SORL1 | 4.33e-06 | 790 | 154 | 17 | M12490 |
| Coexpression | GABRIELY_MIR21_TARGETS | WNT5A SMC5 TGFB2 POLR3B PIK3R1 USP7 RAI14 LIMCH1 EPHA4 FILIP1L | 8.64e-06 | 289 | 154 | 10 | M2196 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.19e-05 | 300 | 154 | 10 | M8702 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | WNT5A SMC5 DCUN1D4 TGFB2 BPTF DST BAZ1A ZC3H4 BUB1B LIMCH1 EPHA4 FILIP1L | 2.13e-05 | 466 | 154 | 12 | M13522 |
| Coexpression | GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 2.26e-05 | 197 | 154 | 8 | M7403 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | DOCK2 HLA-DRB1 NCF1 KRI1 ITGB7 ADD3 DST SLC12A4 GVINP1 P3H2 PIK3R1 EPHA4 | 3.14e-05 | 485 | 154 | 12 | M8513 |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | KRT18 HSPH1 SMC4 ADD3 MYO5C DST TCERG1 BAZ1A NFIC EIF3A HSPA5 | 8.80e-05 | 458 | 154 | 11 | M40010 |
| Coexpression | GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN | 1.08e-04 | 183 | 154 | 7 | M8189 | |
| Coexpression | WANG_CISPLATIN_RESPONSE_AND_XPC_UP | 1.16e-04 | 185 | 154 | 7 | M19511 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 1.17e-04 | 81 | 154 | 5 | M45667 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP | 1.60e-04 | 195 | 154 | 7 | M7397 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP | 1.76e-04 | 198 | 154 | 7 | M5289 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP | 1.76e-04 | 198 | 154 | 7 | M5287 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 1.81e-04 | 199 | 154 | 7 | M316 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 1.81e-04 | 199 | 154 | 7 | M7553 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_24H_BMDC_DN | 1.81e-04 | 199 | 154 | 7 | M3821 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.81e-04 | 199 | 154 | 7 | M5893 | |
| Coexpression | GSE7460_CD8_TCELL_VS_TREG_ACT_DN | 1.81e-04 | 199 | 154 | 7 | M5684 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP | 1.87e-04 | 200 | 154 | 7 | M4626 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 1.87e-04 | 200 | 154 | 7 | M4512 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 1.87e-04 | 200 | 154 | 7 | M3513 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.87e-04 | 200 | 154 | 7 | M6237 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP | 1.87e-04 | 200 | 154 | 7 | M3842 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.87e-04 | 200 | 154 | 7 | M6662 | |
| Coexpression | HALLMARK_ESTROGEN_RESPONSE_LATE | 1.87e-04 | 200 | 154 | 7 | M5907 | |
| Coexpression | GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP | 1.87e-04 | 200 | 154 | 7 | M9273 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.93e-04 | 90 | 154 | 5 | M39250 | |
| Coexpression | FISCHER_DREAM_TARGETS | SMARCA5 NUP107 CWC27 SMC4 SMC5 HNRNPA1 NUP54 NCOA5 PPP1R10 TCERG1 SMC3 BUB1B EIF3A NUP93 LAS1L ESPL1 | 1.95e-04 | 969 | 154 | 16 | M149 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | WNT5A KRI1 HNRNPA1 DST SLC12A4 PIK3R1 RAI14 LIMCH1 HERC1 ESPL1 FILIP1L | 2.10e-04 | 506 | 154 | 11 | M253 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | SMARCA5 VEZT CAMK4 HSPH1 SMC4 SRP72 ADD3 NUP54 ANKRD36B TCERG1 SMC3 PCMTD2 ANKRD36 | 2.19e-04 | 687 | 154 | 13 | M41022 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 3.92e-06 | 175 | 148 | 9 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 8.33e-06 | 192 | 148 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | NAALAD2 WNT5A FAT3 SMC4 ADD1 ADD3 TGFB2 PIK3R1 USP7 EIF3A DNAJC1 HERC1 | 2.86e-05 | 406 | 148 | 12 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | NAALAD2 WNT5A FAT3 TM9SF1 SMC4 ADD1 ADD3 TGFB2 PIK3R1 USP7 DNAJC1 HERC1 | 3.37e-05 | 413 | 148 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.74e-05 | 232 | 148 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | NAALAD2 SMARCA5 WNT5A FAT3 TM9SF1 SMC4 SRP72 ADD1 ADD3 TGFB2 VPS13D NFIC PIK3R1 USP7 EIF3A DNAJC1 HERC1 | 3.76e-05 | 790 | 148 | 17 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | NAALAD2 SMARCA5 WNT5A FAT3 TM9SF1 SMC4 SRP72 ADD1 ADD3 TGFB2 NFIC PIK3R1 USP7 PCMTD2 EIF3A DNAJC1 HERC1 | 4.47e-05 | 801 | 148 | 17 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | DOCK1 SMARCA5 TRAF5 SETX NAB1 SMC4 ATL3 TMTC2 ADD3 NEMP2 TGFB2 ZFHX4 TTC21B SMARCA1 USP7 GRAMD1C EPHA4 | 5.21e-05 | 811 | 148 | 17 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.24e-05 | 138 | 148 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SMARCA5 SETX ERCC6 HSPH1 SMC4 SMC5 ZBED4 TCERG1 SMC3 BAZ1A USP7 EIF3A HSPA5 | 9.29e-05 | 532 | 148 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_500 | 1.97e-04 | 120 | 148 | 6 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_500 | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 2.67e-08 | 193 | 155 | 9 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.79e-08 | 194 | 155 | 9 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.48e-08 | 199 | 155 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.48e-08 | 199 | 155 | 9 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-08 | 199 | 155 | 9 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.63e-08 | 200 | 155 | 9 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.15e-07 | 178 | 155 | 8 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-07 | 179 | 155 | 8 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.02e-07 | 199 | 155 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.02e-07 | 199 | 155 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.02e-07 | 199 | 155 | 8 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-06 | 173 | 155 | 7 | da0f1461643294f92e20b5e456a50211a2780a91 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.74e-06 | 175 | 155 | 7 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.71e-06 | 190 | 155 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.87e-06 | 191 | 155 | 7 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-naive_B_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-06 | 191 | 155 | 7 | a073d58154c801ec499fd969f42b7f1ee7f15d79 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.87e-06 | 191 | 155 | 7 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 5.04e-06 | 192 | 155 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.04e-06 | 192 | 155 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.40e-06 | 194 | 155 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.58e-06 | 195 | 155 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.97e-06 | 197 | 155 | 7 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | PSB|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.17e-06 | 198 | 155 | 7 | 4e6b0d1abc55d7a0d89bd7ecf0f13dc5bed66626 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.37e-06 | 199 | 155 | 7 | cd581d7330b471431ef427f8a4f5be553f70e068 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-06 | 200 | 155 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.59e-06 | 200 | 155 | 7 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | 159377d904394d91e09913131e9a93e08189955a | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.59e-06 | 200 | 155 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.59e-06 | 200 | 155 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.59e-06 | 200 | 155 | 7 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.59e-06 | 200 | 155 | 7 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | 3ce8a2db8c25e1169a0a544f644a63104749c5ee | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | 0bfd41c12887479ceb62c3db0a3c3ba5007eb62b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.59e-06 | 200 | 155 | 7 | d30316836494f33ca46d4e415fd2ed179e9cb5ee | |
| ToppCell | Sepsis-URO-Myeloid-cDC1|URO / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | c5ca81218be40b30e2f9252c1a004cb95d988447 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.87e-05 | 157 | 155 | 6 | d4908cafd8870c1c225817f589ea2bce116ac7ab | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.47e-05 | 165 | 155 | 6 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | (07)_Ionocytes-(2)_GFP_FOXI1|(07)_Ionocytes / shred by cell type by condition | 3.12e-05 | 172 | 155 | 6 | 5776b638b845d054f6e884e7df0412477f48517d | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 174 | 155 | 6 | 33386750842c47ad7e7286d0f26a556da1a2de02 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-regulatory_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-05 | 174 | 155 | 6 | 9344d4e76d7d9429aea87d3c0b98246200d16014 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-05 | 180 | 155 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-05 | 181 | 155 | 6 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 4.15e-05 | 181 | 155 | 6 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.15e-05 | 181 | 155 | 6 | 768d14c452192f92fa557ae59e84c43436f575f0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 4.15e-05 | 181 | 155 | 6 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 4.28e-05 | 182 | 155 | 6 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 184 | 155 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.55e-05 | 184 | 155 | 6 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.69e-05 | 185 | 155 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 4.69e-05 | 185 | 155 | 6 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 4.69e-05 | 185 | 155 | 6 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-05 | 186 | 155 | 6 | 9a7932d0a208f3997216bd21a72913cc82b59fc9 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.97e-05 | 187 | 155 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.12e-05 | 188 | 155 | 6 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.12e-05 | 188 | 155 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-05 | 188 | 155 | 6 | cd833a125a5279ac32a9a9cb9ecd05ae24bea3a9 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 5.12e-05 | 188 | 155 | 6 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.28e-05 | 189 | 155 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 190 | 155 | 6 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 5.43e-05 | 190 | 155 | 6 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 190 | 155 | 6 | 902afe2121593ae08d083c2cea2d1ba9f848574a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.43e-05 | 190 | 155 | 6 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.43e-05 | 190 | 155 | 6 | 1634a6044dce4e026a63976031a498c7460e3dce | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 190 | 155 | 6 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 190 | 155 | 6 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | wk_08-11-Epithelial-PNS-Schwann_precursor|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 190 | 155 | 6 | 4a777d8aa19cadd3b61b023772df142421a89113 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.43e-05 | 190 | 155 | 6 | 08813c2f9321b82f0ec66854bb7a383aa1171780 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-05 | 191 | 155 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.59e-05 | 191 | 155 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 5.76e-05 | 192 | 155 | 6 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 5.76e-05 | 192 | 155 | 6 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.76e-05 | 192 | 155 | 6 | 3ce5dbde41aeb73d49f2c7991d34682f0827fa5a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.76e-05 | 192 | 155 | 6 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 5.76e-05 | 192 | 155 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.93e-05 | 193 | 155 | 6 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.93e-05 | 193 | 155 | 6 | 947200ef6c3a2e35ad7e6b4af29d92384bdf73f5 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.93e-05 | 193 | 155 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.10e-05 | 194 | 155 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.10e-05 | 194 | 155 | 6 | 4a4cc61193344bb151439f63d0584abddde47cf0 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.27e-05 | 195 | 155 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 195 | 155 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.27e-05 | 195 | 155 | 6 | 146e482f660c0f234a3d15495ad9e7ed7b88fdc8 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.27e-05 | 195 | 155 | 6 | efc71886b8521539dcba9d5c1a8304eec2dc6c42 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.27e-05 | 195 | 155 | 6 | 97a9410f47beca02346902d078288a75bfe6e56b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.27e-05 | 195 | 155 | 6 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 195 | 155 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 6.45e-05 | 196 | 155 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-05 | 196 | 155 | 6 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 6.45e-05 | 196 | 155 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_naive|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.45e-05 | 196 | 155 | 6 | de43dd0697e1daf4d50800957cf0b27b54a7a333 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | DNAH3 HSPA4L DCUN1D4 ERLIN1 BMP7 VPS13D MTUS1 NFIC RAI14 IL17RB | 5.85e-07 | 190 | 151 | 10 | 6945_DN |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 6.66e-06 | 196 | 151 | 9 | 4776_DN | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 7420_DN | |
| Drug | 0225151-0000 [351320-15-5]; Down 200; 10uM; PC3; HT_HG-U133A | 7.22e-06 | 198 | 151 | 9 | 6426_DN | |
| Drug | Cytisine (-) [485-35-8]; Down 200; 21uM; HL60; HG-U133A | 7.22e-06 | 198 | 151 | 9 | 1766_DN | |
| Drug | Griseofulvin [126-07-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | DENND5B NAALAD2 VEZT SMC4 ADAMTS13 VPS13D ZFHX4 SYNJ2 LIMCH1 | 7.52e-06 | 199 | 151 | 9 | 4687_UP |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | NUP107 HSPA4L SMC4 TMTC2 REEP3 ADD3 TGFB2 PPP1R10 BMP7 NPHP3 KIDINS220 SLC12A4 MTUS1 BUB1B FIBP HERC1 ESPL1 EPHA4 FILIP1L | 2.10e-05 | 961 | 151 | 19 | ctd:C029497 |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.17e-05 | 174 | 151 | 8 | 5260_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.46e-05 | 177 | 151 | 8 | 4768_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.00e-05 | 182 | 151 | 8 | 3630_DN | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.37e-05 | 185 | 151 | 8 | 4755_DN | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 3.78e-05 | 188 | 151 | 8 | 595_DN | |
| Drug | DMEQ-TAD | 4.37e-05 | 2 | 151 | 2 | CID000131554 | |
| Drug | Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 3284_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.08e-05 | 196 | 151 | 8 | 5257_DN | |
| Drug | Methylmercury Compounds | DLG5 PLOD3 SMC4 ADAMTS13 HNRNPA1 TGFB2 SMC3 PIK3R1 BUB1B USP7 CCNA1 RAI14 LTV1 HNRNPLL HSPA5 CNP SDHA | 5.18e-05 | 851 | 151 | 17 | ctd:D008767 |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 1224_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 6091_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.26e-05 | 197 | 151 | 8 | 5746_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; HL60; HG-U133A | 5.26e-05 | 197 | 151 | 8 | 1589_DN | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; HL60; HG-U133A | 5.46e-05 | 198 | 151 | 8 | 1624_UP | |
| Drug | Pivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 6014_UP | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 5.46e-05 | 198 | 151 | 8 | 4792_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; PC3; HT_HG-U133A | 5.65e-05 | 199 | 151 | 8 | 5836_DN | |
| Drug | Thiram | SMARCA5 PLOD3 ATL3 MSTO1 ADD1 ADD3 NUP54 TGFB2 PPP1R10 SMC3 ATP6V1D LTV1 SDHA | 5.80e-05 | 533 | 151 | 13 | ctd:D013893 |
| Disease | liver disease (is_marker_for) | 2.60e-05 | 2 | 151 | 2 | DOID:409 (is_marker_for) | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 7.78e-05 | 3 | 151 | 2 | DOID:0081361 (implicated_via_orthology) | |
| Disease | anti-basement membrane glomerulonephritis (is_implicated_in) | 1.55e-04 | 4 | 151 | 2 | DOID:4780 (is_implicated_in) | |
| Disease | phospholipids:total lipids ratio | 1.76e-04 | 227 | 151 | 7 | EFO_0020946 | |
| Disease | allergic asthma (is_implicated_in) | 2.58e-04 | 5 | 151 | 2 | DOID:9415 (is_implicated_in) | |
| Disease | Human papillomavirus infectious disease (is_implicated_in) | 3.85e-04 | 6 | 151 | 2 | DOID:11166 (is_implicated_in) | |
| Disease | extranodal nasal NK/T cell lymphoma | 3.85e-04 | 6 | 151 | 2 | MONDO_0019472 | |
| Disease | Angioedema | 3.85e-04 | 6 | 151 | 2 | C0002994 | |
| Disease | Severe Congenital Microcephaly | 5.32e-04 | 31 | 151 | 3 | C3853041 | |
| Disease | narcolepsy (is_implicated_in) | 5.37e-04 | 7 | 151 | 2 | DOID:8986 (is_implicated_in) | |
| Disease | Microlissencephaly | 6.40e-04 | 33 | 151 | 3 | C1956147 | |
| Disease | Sarcoidosis | 7.14e-04 | 8 | 151 | 2 | C0036202 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 7.14e-04 | 8 | 151 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | NEPHRONOPHTHISIS 2 | 7.14e-04 | 8 | 151 | 2 | C1865872 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 9.21e-04 | 145 | 151 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.14e-03 | 10 | 151 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | Berylliosis | 1.39e-03 | 11 | 151 | 2 | C0005138 | |
| Disease | Beryllium Disease | 1.39e-03 | 11 | 151 | 2 | C2350873 | |
| Disease | triacylglycerol 56:2 measurement | 1.39e-03 | 11 | 151 | 2 | EFO_0010429 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.58e-03 | 97 | 151 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | myopathy (implicated_via_orthology) | 1.92e-03 | 48 | 151 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | autoimmune hepatitis (is_implicated_in) | 1.96e-03 | 13 | 151 | 2 | DOID:2048 (is_implicated_in) | |
| Disease | Nephronophthisis | 1.96e-03 | 13 | 151 | 2 | C0687120 | |
| Disease | acute myeloid leukemia (is_marker_for) | 2.04e-03 | 49 | 151 | 3 | DOID:9119 (is_marker_for) | |
| Disease | lung adenocarcinoma | 2.06e-03 | 174 | 151 | 5 | EFO_0000571 | |
| Disease | generalised epilepsy | 2.42e-03 | 52 | 151 | 3 | EFO_0005917 | |
| Disease | Drug habituation | 2.93e-03 | 115 | 151 | 4 | C0013170 | |
| Disease | Drug abuse | 2.93e-03 | 115 | 151 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.93e-03 | 115 | 151 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.93e-03 | 115 | 151 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.93e-03 | 115 | 151 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.93e-03 | 115 | 151 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.93e-03 | 115 | 151 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.93e-03 | 115 | 151 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.93e-03 | 115 | 151 | 4 | C0029231 | |
| Disease | pemphigus vulgaris | 2.98e-03 | 16 | 151 | 2 | EFO_0004719 | |
| Disease | Urticaria | 2.98e-03 | 16 | 151 | 2 | C0042109 | |
| Disease | central nervous system disease (implicated_via_orthology) | 2.98e-03 | 16 | 151 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | cathepsin L1 measurement | 2.98e-03 | 16 | 151 | 2 | EFO_0010619 | |
| Disease | Substance abuse problem | 3.03e-03 | 116 | 151 | 4 | C0740858 | |
| Disease | Amyotrophic Lateral Sclerosis | 3.30e-03 | 58 | 151 | 3 | C0002736 | |
| Disease | Moyamoya Disease | 3.36e-03 | 17 | 151 | 2 | C0026654 | |
| Disease | longevity | 3.51e-03 | 284 | 151 | 6 | EFO_0004300 | |
| Disease | response to vaccine | 3.63e-03 | 122 | 151 | 4 | EFO_0004645 | |
| Disease | disease progression measurement | 3.81e-03 | 61 | 151 | 3 | EFO_0008336 | |
| Disease | hepatitis B virus infection | 4.20e-03 | 19 | 151 | 2 | EFO_0004197 | |
| Disease | Prostatic Neoplasms | 4.57e-03 | 616 | 151 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.57e-03 | 616 | 151 | 9 | C0376358 | |
| Disease | sexual dimorphism measurement | CACNA2D2 ADAMTS13 DCUN1D4 TGFB2 BPTF NF1 ZC3H4 NFIC PIK3R1 DNAJC1 NUP93 HERC1 METTL15 | 4.59e-03 | 1106 | 151 | 13 | EFO_0021796 |
| Disease | alcohol consumption measurement | DOCK1 DLG5 TRAF5 JAKMIP3 HNRNPA1 ERLIN1 NF1 ZC3H4 RALGPS1 ANKRD36 METTL15 CDH18 EPHA4 SORL1 | 4.75e-03 | 1242 | 151 | 14 | EFO_0007878 |
| Disease | bitter alcoholic beverage consumption measurement | 4.93e-03 | 133 | 151 | 4 | EFO_0010092 | |
| Disease | Microcephaly | 4.95e-03 | 67 | 151 | 3 | C0025958 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NELYYEEAEHERRVK | 341 | Q8TAA9 | |
| AQRDYEKAIKFYREA | 896 | Q7Z4L5 | |
| EYEARENFRKADAIF | 161 | O60566 | |
| IYRYAFDFAREKDQR | 196 | Q92564 | |
| YKESREARFYLVDSE | 406 | Q8IYS0 | |
| AVAEYRREKQKYEAL | 356 | Q6UX04 | |
| KSLDERYIDEVTRNY | 611 | Q9NY47 | |
| KERYFDRINENDPEY | 21 | Q9UEY8 | |
| REDYEDFEYIRRQKQ | 241 | Q8IUX7 | |
| ALDLDEVIKVYRYFA | 136 | P30837 | |
| AVFDIVRNYTADYDK | 101 | O75477 | |
| ARLEKEFYRENYVSR | 196 | P49640 | |
| ARLEKEFYRENYVSR | 201 | Q03828 | |
| DYELRYLVFKDDRNT | 911 | Q7Z2Y8 | |
| RRREAQEKGYYYDLD | 746 | Q14687 | |
| QRFLERYIYNREEFA | 51 | P04440 | |
| FDLIYEYERKRYEDL | 246 | A6QL64 | |
| SEAENRVIFDLIYEY | 226 | Q8N2N9 | |
| VDEIRNYFGEKVALY | 176 | A1A5B4 | |
| VQRRYYEKLTEFVAD | 2981 | Q12830 | |
| AAEFRIYKDYIRERF | 171 | P18075 | |
| IYKDYIRERFDNETF | 176 | P18075 | |
| AIYEVLKDDERRQRY | 111 | Q96KC8 | |
| IYRYAFDFARDKDQR | 141 | Q9BTE7 | |
| RYRDDGDEDYYKQRL | 451 | Q03468 | |
| IIYDNLRAEVFNYRE | 576 | Q7L311 | |
| EDADIQVYRRYGEEY | 651 | Q76LX8 | |
| DDIFAYVKDRYFVEE | 106 | Q9NRL2 | |
| EALQYFYFLRDEKDS | 546 | Q8N1F7 | |
| LRDYFEQYGKIEVIE | 121 | Q32P51 | |
| LRDYFEQYGKIEVIE | 76 | A0A2R8Y4L2 | |
| LYKEAQAELEDYRKR | 651 | Q9P0K7 | |
| FELEYFYEEQCRRLD | 411 | Q9Y5P8 | |
| RYIEELQKFVEDDNY | 266 | Q5JS13 | |
| TYEEDREYESQAKRL | 11 | Q8WVV9 | |
| EDELFNRYERAIYAA | 416 | P57740 | |
| EVRYSFRYVDDKAAQ | 276 | O60330 | |
| ELVEKEELGFFQYYR | 266 | Q08AF8 | |
| RYRDDGDEDYYKQRL | 451 | P0DP91 | |
| KDDDDDQLFYTRLYL | 186 | O60568 | |
| FDRQARRLAYYADKE | 556 | Q6NSJ2 | |
| TDKVQAEYRDAYREY | 1376 | Q9ULH0 | |
| YDELARKNREELDKY | 256 | P05783 | |
| YKSRYEEALREEEEQ | 301 | A8MXT2 | |
| ERFEKFYEQYDDDEI | 261 | Q96GA3 | |
| EEKRVFQEQERYRYS | 516 | Q6P4R8 | |
| TERENRLKEFYTREY | 1001 | Q9ULD2 | |
| YTREYEKLRDTYIEE | 1011 | Q9ULD2 | |
| EEEIRKYSAIYGRFD | 246 | Q13506 | |
| LFDRIVEKGYYSERD | 126 | Q16566 | |
| QEYLQAYEDVLERYK | 16 | Q03001 | |
| YVNYARTEDFFKLER | 176 | Q04609 | |
| TFSNRKEYVERAIEY | 4676 | Q15751 | |
| RNDAKNAVEEYVYEF | 631 | Q92598 | |
| VYFREIDTKDDYNAL | 446 | Q9NRM6 | |
| ERKKVYRAEYINFLE | 1176 | Q5H9U9 | |
| YYESDNDKERFIREN | 126 | P54764 | |
| QAFRAIDRADYYLEE | 31 | Q9NV79 | |
| IDRADYYLEEFKENA | 36 | Q9NV79 | |
| KYQEELEDRLHFYVE | 206 | Q9BUK6 | |
| SEKVVYRRFTEIYEF | 36 | P14598 | |
| VKYLTEDEYREQADA | 331 | A6NFY4 | |
| YRQYFEEIQRRFDAE | 181 | Q9HCD5 | |
| EKDEHGRAYYEFREE | 206 | Q1KMD3 | |
| YREERDAVYSEYKLI | 421 | Q8TDM6 | |
| FYIRALYDRLADVEQ | 1596 | Q8TDM6 | |
| TEVFEEVYNYLKRAR | 581 | Q8NG66 | |
| YLDEELDYRKQALDQ | 721 | Q5VZ66 | |
| YEEEQFTVLEKFRYL | 276 | Q9Y4W2 | |
| RDYILNKRYEEEEEE | 241 | Q8N9T8 | |
| YDRFVLYKEGERDFL | 251 | Q6PI73 | |
| TAEKYREYEAREQTD | 36 | P0C7V9 | |
| FYDISEKARRIVESY | 531 | Q8IVL5 | |
| FQEKSREYDRLYEEY | 456 | P27986 | |
| TAEKYREYEAREQTD | 36 | A6NJ78 | |
| EIYDRREYSRFEKEQ | 751 | P26010 | |
| ERYYIDADLLREIKQ | 451 | Q7Z3B4 | |
| KFAYRYRSDSQDEVE | 281 | Q15390 | |
| AVFYKDVRAYRQLLE | 76 | Q5SZD4 | |
| YKEVDRARTIYERFV | 356 | Q9BZJ0 | |
| DLNYEDKLQEDRFLY | 716 | Q14674 | |
| ELVEKEELGFFQYYR | 266 | Q0D2H9 | |
| VFIYRGKEYERREDF | 1356 | Q14185 | |
| FIYRGKEYERREDFQ | 1361 | Q92608 | |
| EVYRVFYDRLIDKED | 2306 | Q8TD57 | |
| ERRITYYREKEEEEQ | 801 | Q14152 | |
| YYREKEEEEQRRAEE | 806 | Q14152 | |
| KTEDEYETLERRYAN | 651 | Q4L180 | |
| YETLERRYANERDKA | 656 | Q4L180 | |
| YAEEIYQYLREAEIR | 211 | P78396 | |
| YDEKNRYDLEILAVD | 221 | Q8TDW7 | |
| FVDDEELAYVIQRYR | 146 | Q9Y3A0 | |
| LYKRYAFLRCEEERE | 896 | Q6ZUT9 | |
| ERVRFLDRYFYNQEE | 51 | P01911 | |
| FSEEYKRLDEDLAAY | 96 | P09543 | |
| FRYQQELEEEIKELY | 411 | Q6DD88 | |
| RNEEIKKAQEDYDRY | 161 | Q8TC29 | |
| YFEQKDSDNYRVFER | 166 | Q9BS26 | |
| LVRYFINYNVEDDRF | 416 | Q13634 | |
| RYKEEYAVLISEAQA | 3446 | Q14204 | |
| ERFKLLQEYVYEHER | 1101 | Q13255 | |
| KERIDTRNELESYAY | 556 | P11021 | |
| EERKRDFEKIFAYYD | 196 | O76038 | |
| EREDRAKYKDSYNVF | 61 | Q6ISS4 | |
| AQKEVEEEERRYYEE | 806 | Q9UPQ0 | |
| LLIERYYAFDEAFVR | 91 | O43427 | |
| FSDYVEVAKAQDYDR | 501 | Q96KR7 | |
| EEEFDIVKAARYKYQ | 426 | O15034 | |
| YQARERDVERFFKGY | 11 | Q08170 | |
| EENEFILYAVRKSIY | 756 | Q92673 | |
| DSYVLEYRKINRDDE | 446 | Q9NQ86 | |
| ARVEELDRKYYEVKN | 446 | Q9UQE7 | |
| RERKANYAVDAYFRE | 751 | P28370 | |
| EEKVAYQSYERARDI | 591 | O75069 | |
| IEEKVAYQAYERSRD | 361 | Q9ULS5 | |
| IDLTYEEVFYFVKRQ | 731 | O15056 | |
| AHAREDYKVRIDEYD | 591 | P31040 | |
| SYDRFVLYKEGERDF | 251 | O75019 | |
| YAAAEYERLRKEYEI | 86 | Q7Z494 | |
| YDKAEELYERALDIR | 1151 | Q7Z494 | |
| IYRTFRDEEGKEYVR | 1186 | Q8IZX4 | |
| FAYDVKREVYNEETF | 21 | Q96RN1 | |
| RNLGKVDRDDYYDLQ | 176 | Q7Z333 | |
| EEEYEAHYIRRQDLK | 511 | Q9Y2E8 | |
| VGQDRRRDITYEYKY | 426 | P49221 | |
| SFEKAYCEYRLNRIE | 81 | O76094 | |
| LDLYLAYFVRERDAE | 176 | P08651 | |
| REIDDYIVQAKERGY | 101 | Q6NUK4 | |
| ISQRIYKEEREYFDE | 206 | Q9UNH6 | |
| YYDRNLALFEEELDI | 61 | Q9UP95 | |
| IEYQFVERLEERYKC | 31 | O00463 | |
| KERYFDRVDENNPEY | 21 | P35611 | |
| ADEYYIIYRNVFDKV | 46 | Q8NHS4 | |
| RERSDEEYYAKEVYK | 91 | P61812 | |
| AALEKFARQYREAYD | 1931 | Q86UP3 | |
| RDNELLVYKERVGEY | 76 | P02743 | |
| QREFEEYIRDKYITA | 1001 | O14776 | |
| KNAVEEYVYDFRDRL | 621 | O95757 | |
| DDFKDFSLLYEEARY | 126 | Q96SI1 | |
| NEAAEKYYDLAARLR | 761 | Q8N394 | |
| YIITELDEREREEFY | 186 | Q9Y5K8 | |
| DERRLYYEGLQDKLA | 461 | O14964 | |
| EYGYRFAKEFVDARE | 166 | Q9H1J7 | |
| TDEFDQRILYEYLAE | 2631 | P21359 | |
| DKITYERDSFRQAYE | 1111 | Q9NTJ3 | |
| VDDRDYYGNKRLELA | 351 | Q9NW08 | |
| IDYGYRFAKEFVDAR | 186 | P41221 | |
| DYDDFTKELNQYRRA | 216 | Q9UPT8 | |
| DDYDEYSKELNQYRR | 301 | Q9UPT8 | |
| ESYDTENFYFREIRK | 6 | Q6ZN19 | |
| FYYLSQEDKERQKRE | 561 | Q9HBM0 | |
| LRDYFEQYGKIEVIE | 121 | P09651 | |
| RERKANYAVDAYFRE | 736 | O60264 | |
| QRFEARIEDGKLYYD | 251 | Q9H7L9 | |
| ENEEDYDKYGIRIRV | 961 | Q8IY18 | |
| DTFLKRTYEYDDIAQ | 391 | A5PLN9 | |
| KLREYFYFELDETER | 406 | Q96QC0 | |
| SDRREDYYDIQLSIK | 341 | Q93009 | |
| VEQLRQAIEELYYFE | 116 | O15321 | |
| KRTYDSFQDELEDYI | 386 | Q5H9K5 | |
| RYKASLFTEEEAEQY | 1011 | O75132 | |
| DYVDREAIFLEVKYD | 4291 | Q5THJ4 | |
| EKEELGFFQYYRERC | 436 | A6NN73 | |
| YVNYARTEDFFKLER | 166 | Q9Y3Q0 | |
| RNYEEKGKRYRDAVE | 941 | Q9NQX4 |